Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Autoimmune Disorders01:29

Autoimmune Disorders

390
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
390
T Cell Types and Functions01:24

T Cell Types and Functions

955
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
955
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TRIM55 promotes noncanonical NF-κB signaling and B cell-mediated immune responses by coordinating p100 ubiquitination and processing.

Science signaling·2023
Same author

A BODIPY-based turn-on fluorescent probe for the selective detection of hydrogen sulfide in solution and in cells.

Talanta·2015
Same author

Analysis of sagittal balance using spinopelvic parameters in ankylosing spondylitis patients treated with vertebral column decancellation surgery.

Acta orthopaedica Belgica·2015
Same author

Using a 3D Culture System to Differentiate Visceral Adipocytes In Vitro.

Endocrinology·2015
Same author

Noncontact Monitoring of Blood Oxygen Saturation Using Camera and Dual-Wavelength Imaging System.

IEEE transactions on bio-medical engineering·2015
Same author

Digital human modeling and its applications: Review and future prospects.

Journal of X-ray science and technology·2015

Related Experiment Video

Updated: Jun 9, 2025

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

17.4K

Systemic lupus erythematosus: pathogenesis and targeted therapy.

Xu Su1, Hui Yu2, Qingqiang Lei3

  • 1Medical Research Center, College of Medicine, The Third People's Hospital of Chengdu (Affiliated Hospital of Southwest Jiaotong University, Southwest Jiaotong University, Chengdu, 610031, Sichuan, China.

Molecular Biomedicine
|October 30, 2024
PubMed
Summary

Systemic lupus erythematosus (SLE) is a complex autoimmune disease. This review explores traditional and emerging treatments, highlighting the need for targeted therapies to improve patient outcomes.

Keywords:
Autoimmune diseasesPathogenesisSystemic lupus erythematosusTargeted therapeutic strategies

More Related Videos

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

2.8K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

390

Related Experiment Videos

Last Updated: Jun 9, 2025

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

17.4K
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

2.8K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

390

Area of Science:

  • Immunology
  • Rheumatology
  • Autoimmune Diseases

Background:

  • Systemic lupus erythematosus (SLE) is a complex autoimmune disorder with diverse clinical presentations.
  • Its pathogenesis involves immune dysregulation, loss of tolerance, genetic factors, and environmental triggers.
  • Understanding SLE's multifaceted nature is crucial for effective management.

Purpose of the Study:

  • To comprehensively review the pathogenesis of Systemic Lupus Erythematosus (SLE).
  • To discuss traditional and emerging treatment strategies for SLE.
  • To highlight advancements in targeted therapies for SLE.

Main Methods:

  • Literature review of pathogenesis and treatment strategies for SLE.
  • Analysis of traditional non-specific treatments (cytotoxic drugs, antimalarials, glucocorticoids, NSAIDs).
  • Evaluation of emerging targeted therapies focusing on immune cell modulation.

Main Results:

  • Traditional SLE treatments offer symptomatic relief but have limitations and side effects.
  • Emerging therapies aim to precisely target immune system components like B and T cells.
  • Targeted approaches offer potential for more effective and safer SLE management.

Conclusions:

  • A deeper understanding of SLE pathogenesis is vital for developing novel treatments.
  • Targeted therapies represent a significant advancement in managing SLE.
  • Continued research into targeted strategies is essential for improving SLE patient care.